<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3940872/" ref="ordinalpos=2485&amp;ncbi_uid=5895740&amp;link_uid=PMC3940872" image-link="/pmc/articles/PMC3940872/figure/pone-0090275-g006/" class="imagepopup">Figure 6. α-Br-TMC inhibits the STAT5 <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> in both a JAK2-dependent and -independent manner..  From: The Synthetic ?-Bromo-2?,3,4,4?-Tetramethoxychalcone (?-Br-TMC) Inhibits the JAK/STAT <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">(<b>A</b>) Ba/F3-1*6 and K562 cells were treated for 60 minutes with the indicated compounds. Protein whole cell extracts were analyzed by Western-Blot using antibodies specific for pSTAT5, STAT5A, STAT5B, STAT5A and B and α-tubulin as a loading control. (<b>B</b>) Ba/F3 cells were pre-treated 30 minutes with 10 µM α-Br-TMC and stimulated with 5 ng/mL IL-3 for 5 minutes. Ba/F3-1*6 and K562 cells were treated with 10 µM α-Br-TMC for 90 minutes. DMSO (Veh.) was adjusted to 0.01% in all conditions. Protein whole cell extracts were analyzed by Western-Blot using antibodies specific for pSTAT5, pJAK2, STAT5A, STAT5B, STAT5A and B, JAK2 and α-tubulin (loading control).</div></div>